NF1 and neoplasm: 30% (6/20) of children with pathogenic NF1 variation and 50% (10/20) of patients without pathogenic NF1 variation, as well as 27% (8/30) of NIH positive and 30% (3/10) of NIH negative individuals had a minimum of one neoplasm.